Pharming Group N.V. (AMS:PHARM)

Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	880	627	690	707	503	812
Market Cap Growth	22.88%	-9.08%	-2.41%	40.66%	-38.05%	-17.99%
Enterprise Value	882	587	658	657	487	787
Last Close Price	1.28	0.93	1.03	1.08	0.78	1.27
PE Ratio	-	-	-	55.27	35.75	26.30
Forward PE	62.67	-	163.65	27.10	16.92	15.76
PS Ratio	3.04	2.19	3.11	3.68	2.88	4.68
PB Ratio	4.32	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	9.98	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	34.30	-	-	35.85	21.10	12.57
P/OCF Ratio	33.30	-	-	33.66	15.11	11.87
EV/Sales Ratio	3.05	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	36.27	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	55.34	-	-	67.70	23.07	12.62
EV/FCF Ratio	34.38	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.54	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	4.35	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	4.26	-	-	7.91	5.97	2.05
Asset Turnover	0.79	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.59	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.04	2.96	3.28	3.90	4.69	3.09
Current Ratio	2.80	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	-3.70%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	2.85%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Capital (ROIC)	3.45%	-0.62%	-3.57%	1.79%	4.29%	18.30%
Return on Capital Employed (ROCE)	5.50%	-	-	2.80%	6.80%	22.30%
Earnings Yield	-0.79%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	2.92%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	-1.47%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.